Patient and Partner Perception After Remission of Cushing's Syndrome
NCT ID: NCT03607474
Last Updated: 2023-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1 participants
OBSERVATIONAL
2018-03-30
2023-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of our study is to evaluate the difference of perception of the quality of life and body image between patients in remission of hypercortisolism, and their caregivers. Secondary objectives will be to evaluate the quality of life of the caregivers, the coping strategies, and the depression/anxiety parameters of both the patient and the caregiver. Patients and methods: the study is Observative, prospective and non-randomized. Inclusion criteria will be patients, aged more than 18, with hypercortisolism in remission for at least 1 year. Self-questionnaires on quality of life, body image, coping, depression and anxiety will be provided to the patient and his/her caregiver. Fulfilling will be blind between the patient and his/her caregiver. Inclusion period will be 12 months.
Results will be compared between the patient and his/her caregiver. Expected results: investigators anticipate that some caregivers will have a different perception of the general physical and mental condition as stated by the patient. The first time that the quality of life of the caregiver would be also altered.
This original project might lead to modify the management of Cushing's syndrome, by considering both the patient and his/her caregiver on a long term basis after remission.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognition, Steroids, and Imaging in Cushings Disease
NCT00081341
Pathogenesis of Functional Hypothalamic Amenorrhea
NCT01674426
Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism
NCT00666068
Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair
NCT00336726
Perimenopause-Related Mood and Behavioral Disorders
NCT00001231
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Couple (Patients and caregivers)
Patient in remission of hypercortisolism Caregivers will be the spouse or, failing that, a person close to the patient, who has been in regular contact with the patient since taking care of him.
Questionnaires of life quality for patients Questionnaires of life quality for caregivers
Questionnaires of life quality for patients
* the WhoQoL
* a specific scale of Cushing's syndrome
* The Beck II scale
* HAD scale
* Rosenberg questionnaire
* Stunkard, Sorensen and Schlusinger (1983) figurines
* Brief Cope scale
Questionnaires of life quality for caregivers
* the WhoQoL
* The Beck II scale
* HAD scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires of life quality for patients
* the WhoQoL
* a specific scale of Cushing's syndrome
* The Beck II scale
* HAD scale
* Rosenberg questionnaire
* Stunkard, Sorensen and Schlusinger (1983) figurines
* Brief Cope scale
Questionnaires of life quality for caregivers
* the WhoQoL
* The Beck II scale
* HAD scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject presenting a hypercortisolism in remission or controlled by a drug treatment for more than one year.
* Subject with a good understanding of the French language
* Non-institutionalized subject
* Subject whose informed consent could be obtained
Exclusion Criteria
* Subject presenting hypercortisolism in remission for more than 20 years
* Major cognitive impairment that does not allow answering a questionnaire
* Genetic syndrome responsible for hypercortisolism
* Mixed adenoma whose corticotropic share is responsible for hypercortisolism
* Pituitary carcinoma
* Subject refusing to participate in the study
* Subject having no close
* Subject whose relative refuses to answer the questionnaires
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
EMILIE GARRIDO PRADALIE
Role: STUDY_DIRECTOR
APHM DRIC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Des Hopitaux de Marseille
Marseille, PACA, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.